Showing results (1-10 of 484) with videos related to
Sort By:
Pageof 49
Neurodegenerative Disease Management|January 20, 2016
B cell-directed therapies in multiple sclerosisChristiane Gasperi, Olaf Stüve, Bernhard HemmerCurrent Opinion in Neurology|May 17, 2006
Central nervous system infections - a potential complication of systemic immunotherapyBernhard Hemmer, Eiliot Frohman, Hans Peter Hartung, et al.The Lancet. Neurology|June 21, 2005
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosisBernhard Hemmer, Olaf Stüve, Bernd Kieseier, et al.Autoimmunity Reviews|March 1, 2011
The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factorsJohann Sellner, Jörg Kraus, Amer Awad, et al.CNS Neuroscience & Therapeutics|July 15, 2010
The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?Johann Sellner, Martin S Weber, Patrick Vollmar, et al.Current Opinion in Neurology|May 15, 2007
Acute disseminated encephalomyelitis: an acute hit against the brainTil Menge, Bernd C Kieseier, Stefan Nessler, et al.Archives of Neurology|October 12, 2005
Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosisOlaf Stüve, Sabine Cepok, Birte Elias, et al.Annals of Neurology|October 3, 2009
Primary central nervous system lymphoma in a patient treated with natalizumabAndreas Schweikert, Marcus Kremer, Florian Ringel, et al.Archives of Neurology|February 11, 2009
Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosisOlaf Stüve, Verena I Leussink, Ruth Fröhlich, et al.Journal of Neuroimmunology|September 21, 2005
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitroOliver Neuhaus, Heinz Wiendl, Bernd C Kieseier, et al.Pageof 49